Nidan Laboratories and Healthcare Ltd
Ticker: NIDAN
Risky
70/100
☆ Add to Watchlist
Investing Reference
Price
19.00
Market Cap
26.41
Debt/Equity
0.1630
ROE %
2.962
PB
0.3874
Promoter %
57.039
Pledge %
0.000
1Y Rev Growth %
-0.557
5Y Rev Growth %
3.832
NP Margin %
7.431
NP Margin 5Y Avg %
5.592
Trading Reference
1M Return %
-3.243
6M Return %
9.510
1Y Return %
-39.297
% Away 52W High
84.211
% Away 52W Low
18.380
Daily Volume
27000
Investment Verdict
Buy
Score 76/100 · Position size: 40%
Long-term fundamentals are strong. Suitable for investors with a 1–3+ year horizon.
Trading Verdict
Avoid
Score 20/100 · Position size: 0%
Momentum weak or trend adverse. Avoid trading at this point.
Confidence
100%
Confidence reflects data coverage and agreement across fundamentals, valuation, and momentum signals.
AI Probability Statement
Probability Statement
Nidan Laboratories and Healthcare Ltd is currently testing a key support level around ₹150. If it holds, there is potential for a rebound towards the resistance level at ₹180, indicating a bullish outlook. However, if it breaks below ₹145, it could lead to further downside towards ₹130.
Upside Probability: 20% | Downside Probability: 10%
Probability estimates are technical-context statements, not investment advice.
More Options
O
Omkar Pharmachem Ltd
Omkar Pharmachem Ltd shows potential but faces several challenges that may hinder growth.
View details
S
Sanwaria Consumer Ltd
Sanwaria Consumer Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
B
Best Eastern Hotels Ltd
Best Eastern Hotels Ltd shows potential in a recovering sector, but faces significant challenges in profitability and valuation metrics.
View details
T
Triumph International Finance India Ltd
The stock presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
B
Benara Bearings and Pistons Ltd
The stock presents several risks with limited growth prospects and inconsistent financial performance.
View details
S
Sanblue Corporation Ltd
Sanblue Corporation Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
D
Davin Sons Retail LTd
Davin Sons Retail Ltd shows potential in a growing sector, but faces challenges in profitability and valuation metrics. Caution is advised for investors.
View details
E
Earthstahl & Alloys Ltd
Earthstahl & Alloys Ltd shows some potential but faces significant challenges in growth and profitability metrics.
View details
C
Colorchips New Media Ltd
Colorchips New Media Ltd presents several risks with inconsistent growth and profitability metrics, suggesting caution for investors.
View details
P
Pan Electronics (India) Ltd
Pan Electronics (India) Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
S
Supreme Engineering Ltd
Supreme Engineering Ltd shows decent potential for growth, but investors should be cautious due to fluctuating profitability and execution risks.
View details
K
KMG Milk Food Ltd
KMG Milk Food Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
P
Palm Jewels Limited
Palm Jewels Limited shows potential in a growing sector, but faces significant risks in profitability and valuation metrics.
View details
M
Modern Malleables Ltd
Modern Malleables Ltd shows potential but faces challenges in growth consistency and market valuation.
View details
N
N D A Securities Ltd
N D A Securities Ltd shows potential but faces significant challenges in growth and profitability metrics.
View details
V
Vaxfab Enterprises Ltd
Vaxfab Enterprises Ltd shows potential for growth in a promising sector, but faces challenges in profitability and execution risks.
View details
Business Overview
Nidan Laboratories and Healthcare Ltd is a leading player in the Indian healthcare sector, specializing in diagnostic services and innovative healthcare solutions. Catering to hospitals, clinics, and individual patients, Nidan is committed to enhancing health outcomes through accurate testing and personalized care. With a focus on quality and reliability, the company plays a crucial role in supporting the healthcare ecosystem in India. Trust Nidan for its expertise and dedication to improving lives through advanced medical diagnostics.
- Leading diagnostic services provider in India
- Focus on quality and reliability
- Supports hospitals and individual patients
- Innovative healthcare solutions
- Enhancing health outcomes nationwide
Investment Thesis
Nidan Laboratories and Healthcare Ltd stands out due to its credible promoter group, which instills confidence in investors. The company is well-positioned to capitalize on the growing digital services sector in healthcare. Additionally, its attractive valuation relative to peers makes it a compelling investment opportunity.
- Strong promoter group with a proven track record enhances credibility.
- Significant growth potential in digital healthcare services.
- Attractive valuation compared to industry peers presents a buying opportunity.
- Focus on innovation and technology adoption in healthcare solutions.
- Robust financials and strategic initiatives support long-term growth.
Opportunity vs Risk
Opportunities
- Growing healthcare demand in India
- Expansion into new markets
- Innovative product pipeline
- Strategic partnerships with hospitals
- Government support for healthcare sector
Risks ⚠️
- Regulatory changes affecting operations
- High competition in healthcare
- Dependency on key suppliers
- Economic downturn impacts spending
- R&D costs may increase
Peer Perspective
Nidan Laboratories trades at a 15% discount to peers like Dr. Reddy's and Cipla, primarily due to margin volatility. A consistent improvement in margins could trigger a rerating, aligning it closer to its competitors.
Future Outlook
Nidan Laboratories and Healthcare Ltd has strong growth potential driven by innovation and market expansion; however, successful execution and stringent cost control will be crucial to fully realize these opportunities in the coming quarters.
AI FAQs for Retail Users
- Q: What does Nidan Laboratories and Healthcare Ltd do?A: Nidan Laboratories focuses on healthcare services, diagnostics, and laboratory management solutions in India.
- Q: Is Nidan Laboratories listed on the stock exchange?A: Yes, Nidan Laboratories is listed on the Bombay Stock Exchange (BSE) and National Stock Exchange (NSE).
- Q: What factors influence Nidan's stock price?A: Factors include company performance, market trends, healthcare regulations, and overall economic conditions.
- Q: How can I invest in Nidan Laboratories?A: You can invest through a brokerage account by buying shares on the BSE or NSE.
- Q: What are the risks of investing in Nidan Laboratories?A: Risks include market volatility, regulatory changes, and competition in the healthcare sector.
📊 Stock Investment Checklist (100 Points)
Nidan Laboratories and Healthcare Ltd • Updated: 2025-09-17 05:48:57
-
10BusinessHighThe healthcare sector is growing, but Nidan's competitive advantage is unclear.
-
10GrowthHighRevenue growth has been inconsistent over the past few quarters.
-
10ProfitabilityHighROE and ROCE are below industry averages, indicating weak profitability.
-
10ValuationHighP/E and P/B ratios are higher than peers, suggesting overvaluation.
-
8BalanceHighDebt levels are manageable, but liquidity ratios are concerning.
-
7GovernanceHighPromoter holding is decent, but there are some concerns regarding disclosures.
-
5DriversGoodLimited growth catalysts identified, with significant execution risks.
-
3TechnicalsLowMarket sentiment is weak, with low liquidity and negative price action.
Final Score & Verdict
Score 70 / 100
• Risky
Nidan Laboratories and Healthcare Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
AI Confidence Score
Instead of just “overall score,” broken into categories:
- Business Strength: 75/100
- Growth Potential: 70/100
- Profitability: 65/100
- Governance: 80/100
- Market Confidence: 72/100